CRK Recombinant Antibody, RBITC Conjugated
Product Specifications
Background
The Crk-I and Crk-II forms differ in their biological activities. Crk-II has less transforming activity than Crk-I. Crk-II mediates attachment-induced MAPK8 activation, membrane ruffling and cell motility in a Rac-dependent manner. Involved in phagocytosis of apoptotic cells and cell motility via its interaction with DOCK1 and DOCK4. May regulate the EFNA5-EPHA3 signaling.
Synonyms
CRK; CRKII; p38.
Gene ID
1398
Swiss Prot
P46108
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
CRK
Clonality
Recombinant
Conjugation
RBITC
Source
KLH conjugated synthetic peptide derived from human CRK
Applications
WB, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
1398
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15371574 1 Vial
Lentiviral human C4BPB sgRNA gene knockout kit - Lentiviral human C4BPB sgRNA gene knockout kit (25)
Ask
View Details 
MBS1155387-01 0.02 mg (E-Coli)
Recombinant Brucella suis biovar 1 3-dehydroquinate synthase (aroB)
Ask
View Details 
MBS1155387-02 0.02 mg (Yeast)
Recombinant Brucella suis biovar 1 3-dehydroquinate synthase (aroB)
Ask
View Details MBS1155387-03 0.1 mg (E-Coli)
Recombinant Brucella suis biovar 1 3-dehydroquinate synthase (aroB)
Ask
View Details